Marshall M. Urist

14.4k citations

100 papers · 8.5k indexed · 1 hit paper · h-index 44

Oncology top 0.2%
Epidemiology top 1%
Molecular Biology top 5%
Surgery top 2%
Immunology top 2%

Co-authors: Charles M. Balch Seng‐Jaw Soong William A. Maddox Kirby I. Bland Samuel W. Beenken Merrick I. Ross Martin J. Heslin Douglas S. Reintgen
Topics: Cutaneous Melanoma Detection and Management (33 papers)Breast Cancer Treatment Studies (18 papers)Nonmelanoma Skin Cancer Studies (12 papers)
Cited by: Oncology Dermatology Otorhinolaryngology
Journals: Journal of Clinical Oncology The Journal of Immunology Cancer
Partner nations: United States Australia Canada

In The Last Decade

Marshall M. Urist

99 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

2001 1.8k citations Charles M. Balch, Seng‐Jaw Soong et al. profile →

Peers

Countries citing papers authored by Marshall M. Urist

Since Specialization

Citations

This map shows the geographic impact of Marshall M. Urist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall M. Urist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall M. Urist more than expected).

Fields of papers citing papers by Marshall M. Urist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall M. Urist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall M. Urist. The network helps show where Marshall M. Urist may publish in the future.

Co-authorship network of co-authors of Marshall M. Urist

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall M. Urist. A scholar is included among the top collaborators of Marshall M. Urist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall M. Urist. Marshall M. Urist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment patterns for ductal carcinoma in situ with close or positive mastectomy margins 2018 ·Journal of Surgical Research ·Caroline E. Jones,Joshua Richman,Bradford E. Jackson,Audrey S. Wallace,Helen Krontiras,Marshall M. Urist,Kirby I. Bland,Catherine Parker	3
2	A Novel and Accurate Computer Model of Melanoma Prognosis for Patients Staged by Sentinel Lymph Node Biopsy: Comparison with the American Joint Committee on Cancer Model 2012 ·Journal of the American College of Surgeons ·Glenda G. Callender,Jeffrey E. Gershenwald,Michael E. Egger,Charles R. Scoggins,Robert C.G. Martin,Christopher W. Schacherer,Michael J. Edwards,Marshall M. Urist,Merrick I. Ross,Arnold J. Stromberg,Kelly M. McMasters	21
3	Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer 2010 ·Clinical Breast Cancer ·Andres Forero‐Torres,Mansoor N. Saleh,J. Galleshaw,(unknown),Jatin J. Shah,Ivor Percent,Lisle M. Nabell,John T. Carpenter,Carla I. Falkson,Helen Krontiras,Marshall M. Urist,Kirby I. Bland,Jennifer F. De Los Santos,Ruby F. Meredith,(unknown),Wanda K. Bernreuter,Janis P. O’Malley,Yufeng Li,Albert F. LoBuglio	29
4	Ulceration as a Predictive Marker for Response to Adjuvant Interferon Therapy in Melanoma 2010 ·Annals of Surgery ·Kelly M. McMasters,Michael J. Edwards,Merrick I. Ross,Douglas S. Reintgen,Robert C.G. Martin,Marshall M. Urist,R. Dirk Noyes,Jonathan Sussman,Arnold J. Stromberg,Charles R. Scoggins	31
5	Treatment Options for Merkel Cell Carcinoma 2004 ·Journal of the National Comprehensive Cancer Network ·Samuel W. Beenken,Marshall M. Urist	3
6	Occult breast carcinoma presenting with axillary lymph node metastases. 2002 ·PubMed ·Heriberto Medina‐Franco,Marshall M. Urist	23
7	Factors Associated With Local Recurrence After Skin-Sparing Mastectomy and Immediate Breast Reconstruction for Invasive Breast Cancer 2002 ·Annals of Surgery ·Heriberto Medina‐Franco,Luis O. Vásconez,R. Jobe Fix,Martin J. Heslin,Samuel W. Beenken,Kirby I. Bland,Marshall M. Urist	226
8	Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1?4 mm Melanomas 2001 ·Annals of Surgical Oncology ·Charles M. Balch,Seng‐Jaw Soong,Thomas J. Smith,Merrick I. Ross,Marshall M. Urist,Constantine P. Karakousis,Walley Temple,Martín C. Mihm,Raymond L. Barnhill,William R. Jewell,Harry Wanebo,R A Desmond	268
9	Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm) 2000 ·Annals of Surgical Oncology ·(unknown),Seng‐Jaw Soong,M. I. Ross,Marshall M. Urist,Constantine P. Karakousis,Walley Temple,Martín C. Mihm,Raymond L. Barnhill,William R. Jewell,Harry Wanebo,(unknown),(unknown)	340
10	T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection 1999 ·Head & Neck ·Samuel W. Beenken,Helen Krontiras,William A. Maddox,Glenn E. Peters,Seng‐Jaw Soong,Marshall M. Urist	107
11	Clinical Outcomes of Localized Melanoma of the Foot 1998 ·Journal of Clinical Epidemiology ·Lynya Talley,Seng-Jaw Soong,Renée A. Harrison,W. H. McCarthy,Marshall M. Urist,Charles M. Balch	19
12	Increased Survival of Patients Treated With a Vaccinia Melanoma Oncolysate Vaccine 1997 ·Annals of Surgery ·Marc K. Wallack,(unknown),(unknown),Palma M. Shaw,(unknown),Marshall M. Urist,Kirby I. Bland,D. Murray,William A. Robinson,Lawrence E. Flaherty,Jon Richards,Les Rosen,(unknown)	37
13	Surgical management of primary cutaneous melanoma 1996 ·CA A Cancer Journal for Clinicians ·Marshall M. Urist	18
14	Melanoma Recurrence Surveillance Patient or Physician Based? 1995 ·Annals of Surgery ·Charles R. Shumate,Marshall M. Urist,William A. Maddox	49
15	Prognostic factors in minor salivary gland cancer 1995 ·Head & Neck ·(unknown),Samuel W. Beenken,(unknown),Seng‐Jaw Soong,Glenn E. Peters,William A. Maddox,Marshall M. Urist	57
16	Needle-localization biopsy of the breast: impact of a selective core needle biopsy program on yield. 1995 ·Radiology ·Eva Rubin,Peter J. Dempsey,(unknown),W K Bernreuter,Marshall M. Urist,Charles R. Shumate,W. A. Maddox	61
17	1991 national survey of carcinoma of the breast by the Commission on Cancer. 1994 ·PubMed ·R T Osteen,Blake Cady,Joan S. Chmiel,Rosemarie E. Clive,R. L. Scotte Doggett,Michael Friedman,David H. Hussey,William Kraybill,Marshall M. Urist,David P. Winchester	78
18	Efficacy of 2-cm Surgical Margins for Intermediate-Thickness Melanomas (1 to 4 mm) Results of a Multi-institutional Randomized Surgical Trial 1993 ·Annals of Surgery ·(unknown),Marshall M. Urist,Constantine P. Karakousis,Thomas J. Smith,Walley Temple,(unknown),William R. Jewell,Alfred A. Bartolucci,Martín C. Mihm,Raymond L. Barnhill,H. J. Wanebo	348
19	Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer 1992 ·The American Journal of Surgery ·Marty T. Sellers,Samuel W. Beenken,(unknown),Seng-Jaw Soong,Elba A. Turbat‐Herrera,Marshall M. Urist,William R. Maddox	105
20	Squamous cell carcinoma of the buccal mucosa: Analysis of prognostic factors 1987 ·The American Journal of Surgery ·Marshall M. Urist,Christopher J. O’Brien,Seng-Jaw Soong,Daniel W. Visscher,William A. Maddox	107

About Marshall M. Urist

Marshall M. Urist is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 100 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (33 papers), Breast Cancer Treatment Studies (18 papers) and Nonmelanoma Skin Cancer Studies (12 papers). The work is most often cited by research in Oncology (6.3k citations), Dermatology (983 citations) and Otorhinolaryngology (434 citations). Marshall M. Urist has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Charles M. Balch, Seng‐Jaw Soong, William A. Maddox, Kirby I. Bland, Samuel W. Beenken, Merrick I. Ross, Martin J. Heslin, Douglas S. Reintgen, Kelly M. McMasters and Martín C. Mihm. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact